RNDC confirms job cuts from California exit
The major drinks distributor announced plans to leave California last month.
According to a series of Worker Adjustment and Retraining Notification Act (WARN) notices filed by the group on 1 Jul, 1,756 jobs are to be affected.
The layoffs will be effective from 2 September, which is also when RNDC expects to officially exit California.
When it initially announced its departure from the state in June, a company spokesperson said: "We've made the difficult business decision to withdraw from California which affects many of the roles in the state."
The group had seen several significant contracts in the state come to an end in recent months, such as Brown-Forman which shifted to RNDC's peer Reyes Beverage Group in February.
Earlier this year, Tito's Handmade Vodka also switched from RNDC to Reyes Beverage Group for its California distribution.
Other drinks companies working with RNDC include Treasury Wine Estates.
Following the announcement of RNDC's departure from California, in a stock exchange filing at the time, the Penfolds winemaker said the distributor's exit would not impact its financial results in its current financial year, which ended in June.
It added at the time: 'TWE has begun evaluating alternative distribution arrangements for its portfolio in California to determine an appropriate path forward.
'TWE's relationship with RNDC spans 25 US states, including California. The closure of RNDC's California operations is not expected to impact the remainder of its business, and RNDC has reiterated its commitment to investing behind and driving TWE's portfolio in the remaining 24 states.'
In February, the group announced that its president and CEO Nick Mehall would be stepping down after three years.
The company's COO Bob Henrickson was appointed interim CEO, officially entering the role in March.
"RNDC confirms job cuts from California exit" was originally created and published by Just Drinks, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
UnitedHealth Group (UNH) Responds to the Department of Justice
UnitedHealth Group Incorporated (NYSE:UNH) is one of the top low volatility healthcare stocks to buy now. On July 24, UnitedHealth Group Incorporated (NYSE:UNH) released a statement responding to the Department of Justice after a review of the media reports about investigations into specific aspects of its involvement in the Medicare program. A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group Incorporated (NYSE:UNH) stated that it has now begun complying with the formal criminal and civil requests from the Department, and has 'full confidence in its practices and is committed to working cooperatively with the Department throughout this process'. It added that UnitedHealth Group Incorporated (NYSE:UNH) has a historical record of 'responsible conduct and effective compliance,' with independent CMS audits showing that its practices are ranked 'among the most accurate in the industry.' Management stated that after a decade-long civil challenge by the Department to aspects of the company's Medicare Advantage business, 'a court-appointed Special Master concluded there was no evidence to support claims of wrongdoing'. UnitedHealth Group Incorporated (NYSE:UNH) has launched its own initiative to provide confidence and transparency to stakeholders, focusing on conducting 'third-party reviews of policies, practices, and associated processes and performance metrics for risk assessment coding, managed care practices, and pharmacy services.' UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments, which have solid operations. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Entrepreneur
7 minutes ago
- Entrepreneur
Meta Appoints Ex-OpenAI Scientist Shengjia Zhao to Lead New Superintelligence Lab
Zhao, previously a research scientist at OpenAI, played a pivotal role in creating GPT-4 and various lighter models such as version 4.1 and o3. He is among at least eight researchers who have recently transitioned from OpenAI to Meta. You're reading Entrepreneur India, an international franchise of Entrepreneur Media. Meta Platforms has appointed Shengjia Zhao, a leading figure in the development of OpenAI's ChatGPT, as chief scientist of its newly launched Superintelligence Lab. This high-profile move marks a significant step in Meta's accelerating drive to position itself at the forefront of advanced artificial intelligence. CEO Mark Zuckerberg shared the announcement on Friday through Threads. He said Zhao will guide the lab's scientific direction and collaborate closely with both Zuckerberg and Meta's Chief AI Officer Alexandr Wang. Wang joined the company earlier this year after Meta took a substantial stake in his former company, Scale AI. Zhao, previously a research scientist at OpenAI, played a pivotal role in creating GPT-4 and various lighter models such as version 4.1 and o3. He is among at least eight researchers who have recently transitioned from OpenAI to Meta. The influx of talent signals Meta's intent to rapidly close the distance with competitors in the race toward building artificial general intelligence. The creation of the Superintelligence Lab is part of Meta's broader efforts to establish a premier AI research division. The lab is distinct from FAIR, Meta's long-standing AI unit led by deep learning pioneer Yann LeCun. While FAIR has focused on foundational research, the new lab aims to develop what Zuckerberg has described as full general intelligence. Zuckerberg also confirmed that Meta plans to open-source the work produced by the Superintelligence Lab. This strategy has drawn mixed reactions within the AI community, with some praising the transparency and others warning of risks linked to such openness. Meanwhile, Meta's recruitment campaign has unsettled OpenAI. Internal messages leaked this month revealed OpenAI Chief Research Officer Mark Chen comparing Meta's tactics to "someone breaking into our home and stealing something." In response, OpenAI is reportedly reassessing its compensation practices and offering staff additional time off to curb further departures. OpenAI CEO Sam Altman has publicly criticised what he views as profit-driven hiring practices. He alleged that Meta has lured researchers with offers reaching USD 100 million in signing bonuses, a claim dismissed as exaggerated by Meta's Chief Technology Officer Andrew Bosworth. However, reports of even higher offers, including an unverified USD 1.25 billion compensation package over four years, illustrate the escalating competition for elite AI talent. While Altman argues that OpenAI's mission-focused approach offers a stronger long-term foundation, others in the industry see Meta's strategy as justified. Google DeepMind's CEO Demis Hassabis called the hiring surge a rational response given Meta's desire to catch up. With over USD 14 billion invested in AI infrastructure and partnerships, Meta is making its intentions clear. The addition of Zhao and other key hires underscores the company's determination to lead—not just follow—the next wave of AI development.
Forbes
8 minutes ago
- Forbes
Musk Announces Deal With Samsung For Tesla AI Chips Made In Texas
Tesla CEO Elon Musk announced late on Sunday that Samsung will manufacture the car maker's next-generation AI chip at its upcoming Texas semiconductor plant as part of a deal worth $16.5 billion, in a significant boost for Samsung's struggling chipmaking arm. Tesla CEO Elon Musk announced that Samsung will manufacture Tesla's next-generation AI chips. Getty Images In a post on X, Musk announced that 'Samsung's giant new Texas fab will be dedicated to making Tesla's next-generation AI6 chip,' adding: 'The strategic importance of this is hard to overstate.' In a regulatory filing made in South Korea shortly before Musk's announcement, the electronics giant announced it had secured a $16.5 billion contract with a 'large global company.' The multi-year deal will run through till the end of 2033, and Samsung's semiconductor fabrication plant in Taylor, Texas, is scheduled to begin operations in 2026. In a follow-up post, Musk said Samsung has agreed to 'allow Tesla to assist in maximizing manufacturing efficiency,' but he didn't specify whether this meant Tesla would assist in bringing the plant into operation. Musk pointed out the Samsung fab 'is conveniently located not far from my house' and claimed he would walk the production line 'personally to accelerate the pace of progress.' Musk pointed out that Samsung currently manufactures Tesla's AI4 chip. The billionaire said his company has completed the design for the AI5 chip, which will be manufactured by TSMC, Samsung's primary chipmaking rival. According to Musk, the AI5 chips will be first manufactured in Taiwan and then later at TSMC's Arizona plant. How Have The Markets Reacted? Shortly after the announcement, Samsung Electronics' Seoul-traded shares surged 6.22% to $50.6 (KRW 70,000).
